Telegram RegisterThe public register of Telegram
Telegram profile photo for Инновации в фармацевтике

Channel

Инновации в фармацевтике

@chemrarpharma

On this record: Topic · Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

13,139subscribers

-50 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 10,000–31,623.

Register entry

Telegram ID-1001380167234
TypeChannel
Username@chemrarpharma
Created30 August 2019measured — cross-checked against a third-party dataset (ext.tg_channel)
First recorded6 August 2026
Last confirmed live17 September 2026
Measurements held32
Confirmed unchanged1 time, most recently 17 September 2026
On Telegramt.me/chemrarpharma

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 11 September 2026 and assigned it the closest of 31 fixed categories, at 98% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

13,13613,18913,162.56 August 2026 — 13,189 subscribers6 August 2026 — 13,187 subscribers8 August 2026 — 13,188 subscribers9 August 2026 — 13,186 subscribers10 August 2026 — 13,182 subscribers11 August 2026 — 13,185 subscribers12 August 2026 — 13,186 subscribers13 August 2026 — 13,181 subscribers14 August 2026 — 13,182 subscribers16 August 2026 — 13,181 subscribers17 August 2026 — 13,185 subscribers18 August 2026 — 13,182 subscribers19 August 2026 — 13,181 subscribers21 August 2026 — 13,180 subscribers23 August 2026 — 13,181 subscribers24 August 2026 — 13,178 subscribers25 August 2026 — 13,180 subscribers26 August 2026 — 13,178 subscribers27 August 2026 — 13,174 subscribers28 August 2026 — 13,180 subscribers29 August 2026 — 13,175 subscribers30 August 2026 — 13,177 subscribers31 August 2026 — 13,170 subscribers1 September 2026 — 13,164 subscribers2 September 2026 — 13,163 subscribers4 September 2026 — 13,160 subscribers6 September 2026 — 13,154 subscribers9 September 2026 — 13,148 subscribers12 September 2026 — 13,142 subscribers13 September 2026 — 13,136 subscribers15 September 2026 — 13,138 subscribers17 September 2026 — 13,139 subscribers13,1396 August 202617 September 2026
32 measurements spanning 42 days, net -50. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 13,128–13,197 and does not start at zero.
Measurement log — every subscribers count we have recorded, most recent 20 of 32
Measured (UTC)SubscribersChange
17 Sept 2026, 16:2013,139+1
15 Sept 2026, 14:0013,138+2
13 Sept 2026, 21:1913,136-6
12 Sept 2026, 03:1613,142-6
9 Sept 2026, 19:5513,148-6
6 Sept 2026, 14:4013,154-6
4 Sept 2026, 06:1713,160-3
2 Sept 2026, 21:0413,163-1
1 Sept 2026, 21:2513,164-6
31 Aug 2026, 19:0513,170-7
30 Aug 2026, 16:4313,177+2
29 Aug 2026, 19:3413,175-5
28 Aug 2026, 20:3413,180+6
27 Aug 2026, 21:3313,174-4
26 Aug 2026, 22:0713,178-2
25 Aug 2026, 20:5513,180+2
24 Aug 2026, 19:5413,178-3
23 Aug 2026, 01:2813,181+1
21 Aug 2026, 11:1613,180-1
19 Aug 2026, 13:1313,181first reading

Engagement

35 posts held, back to 20 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 49 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
9.70%
avg views ÷ 13,139 subscribers
Avg views / post
1,270
7 posts measured
Reaction rate
1.01%
reactions ÷ views · ER floor
Posts in window
7
of 35 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 2 September 2026
Posts held35 (20 July 20262 September 2026)
Views total8,920
Reactions total90
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken2 Sept 2026, 20:35 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

476 reactions across 33 posts, in 12 distinct kinds. The most used accounts for 35.3% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍16835.3%
🔥14029.4%
11223.5%
😢183.78%
🥰153.15%
🙏81.68%
😁71.47%
🥱30.63%
🤔20.42%
👌10.21%
👏10.21%
🤯10.21%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 35 of the 35 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 509 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 35 most recent posts we hold, published 20 July 2026 to 2 September 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

2 Sept 2026, 09:50 UTC655 views14 reactionsread 2 September 2026
Photo

Novartis сообщает о положительных результатах фазы III КИ ремибрутиниба при рассеянном склерозе Компания сообщила, что ее пероральный ингибитор тирозин-киназы Брутона (BTK), ремибрутиниб, достиг основной цели в двух многоцентровых двойных слепых исследованиях III фазы у взрослых пациентов с рецидивирующим рассеянным склерозом (РРС). Препарат продемонстрировал статистически значимое снижение годовой частоты рецидиво

👍10🔥2🥰2

1 Sept 2026, 08:48 UTC900 views12 reactionsread 2 September 2026
Photo

Препарат Tivicay PD компании ViiV Healthcare получил одобрение FDA для лечения ВИЧ-инфекции у детей FDA одобрило препарат Tivicay PD (долутегравир) компании ViiV Healthcare для применения в сочетании с другими антиретровирусными препаратами у детей с вирусом иммунодефицита человека 1-го типа (ВИЧ-1), вес которых составляет не менее 2 кг. Исследования показали, что долутегравир достигает терапевтических уровней у но

👍11🔥1

31 Aug 2026, 14:13 UTC945 views2 reactionsread 2 September 2026
Photo

Компания Sanyou Bio запускает инновационный центр на основе ИИ для разработки оригинальных лекарств Китайская биотех-компания Sanyou Biopharmaceuticals официально запустила открытую коллаборационную сеть Clicklinks. Проект построен на базе собственных технологических решений компании — платформы AI-STAL и акселератора SAI-DA. Площадка ориентирована на поддержку разработки инновационных лекарственных средств на всех

2

28 Aug 2026, 08:27 UTC≈1,460 views28 reactionsread 2 September 2026
Photo

FDA одобрило революционный препарат для лечения метастатического рака поджелудочной железы Американский регулятор одобрил RASONQUE™ (Daraxonrasib) компании Revolution Medicines — первый препарат широкого спектра действия, нацеленный на RAS, для лечения метастатического рака поджелудочной железы. Препарат также одобрен для пациентов с ранее леченным метастатическим раком протоков поджелудочной железы. Одобрение подт

🔥217

27 Aug 2026, 09:03 UTC≈1,470 views4 reactionsread 2 September 2026
Photo

Компания McKesson приобретет Precision Medicine Group Американская фармацевтическая компания McKesson заявила о намерении приобрести Precision Medicine Group, поставщика услуг в области клинических исследований и коммерциализации биофармацевтических препаратов. Сумма сделки оценивается примерно в $2,25 млрд. Планируемые сроки закрытия не раскрываются, но известно, что после завершения процедуры Precision Medicine G

2👌1🔥1

26 Aug 2026, 08:33 UTC≈1,570 views15 reactionsread 2 September 2026
Photo

Япония первой в мире одобрила препарат GSK для функционального излечения гепатита В Министерство здравоохранения, труда и социального обеспечения Японии (MHLW) выдало регистрационное удостоверение на препарат Hibsago (бепировирсен) для лечения хронического гепатита В. Лекарственное средство предназначено для взрослых пациентов, которые получали нуклеозидные аналоги не менее шести месяцев и соответствуют установленн

👍7🔥53

25 Aug 2026, 08:11 UTC≈1,920 views15 reactionsread 2 September 2026
Photo

Rein Therapeutics получила статус Fast Track Designation для препарата LTI-03 против идиопатического легочного фиброза Биофармацевтическая компания Rein Therapeutics, специализирующаяся на разработке инновационных препаратов для лечения редких заболеваний легких и фиброза, объявила, что американский регулятор присвоил её ведущему кандидату — ингаляционному пептидному препарату LTI-03 — статус ускоренного рассмотрени

👍105

24 Aug 2026, 08:43 UTC≈1,510 views16 reactionsread 2 September 2026
Photo

Производитель первой в мире антитромботической пленки с апиксабаном нацелился на второй по величине рынок лекарственных препаратов в мире Тайваньская биотехнологическая компания TAHO Pharmaceuticals сообщила, что ее ключевой продукт — пероральная антитромботическая пленка BEQIA (TAH3311) — официально поступил на рассмотрение в FDA. Это первый в мире антитромботический препарат в виде тонкой растворимой плёнки для пр

👍10🔥6

21 Aug 2026, 08:20 UTC≈1,800 views21 reactionsread 2 September 2026
Photo

Синегнойную палочку будут выявлять с помощью специальных чернил Плазмонные чернила на основе наночастиц золота для моментальной диагностики этого возбудителя тяжелых внутрибольничных инфекций разработали специалисты Московского физико-технического института (МФТИ) и Московского государственного университета им. Ломоносова (МГУ). «Достаточно взять мазок ватным тампоном, нанести на него плазмонные чернила и поднести

👍16🔥5

20 Aug 2026, 08:16 UTC≈1,850 views18 reactionsread 2 September 2026
Photo

Акции Moderna взлетели на 160% на фоне успеха экспериментальной вакцины от рака кожи Moderna и Merck объявили, что персонализированная мРНК-вакцина против рака снизила риск рецидива и распространения меланомы в ходе клинических испытаний поздней стадии. Компании тестировали вакцину в комбинации с иммунотерапевтическим препаратом Merck Keytruda, который широко применяется для лечения меланомы. По словам президента M

👍117

19 Aug 2026, 09:02 UTC≈1,830 views5 reactionsread 2 September 2026
Photo

Трамп назвал кандидата на пост главы FDA Президент США намерен выдвинуть официального представителя Белого дома Хайди Овертон на должность следующего комиссара Управления по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). На этом посту Овертон сменит Марти Макари, который возглавлял управление с марта 2025 года до своей отставки в мае. Его пребывание на посту было отмечено массовыми увольне

4🔥1

18 Aug 2026, 10:07 UTC≈1,830 views18 reactionsread 2 September 2026
Photo

AstraZeneca прекращает испытание онкопрепарата из-за низкой вероятности успеха Британский фармацевтический гигант сворачивает клинические испытания экспериментального препарата волрустимиг, поскольку он не продемонстрировал явных преимуществ перед существующими методами терапии рака лёгких, в частности, бестселлером Keytruda. В рамках поздней стадии испытаний экспериментальный волрустимиг применялся в комбинации с

😢162

Showing the 12 most recent of 35 posts we hold for @chemrarpharma. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republishes

Channels on the register whose posts this channel has forwarded.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 4 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

Без рецепта
@bezrec · 31,827
Telegram ranks this channel #9 of 98 here — alongside 97 others — read 5 September 2026
Подслушано | Аптека
@podslushano_apteka · 24,488
Telegram ranks this channel #44 of 83 here — alongside 82 others — read 16 September 2026
Слёзы Фармацевта
@katya_farm · 40,797
Telegram ranks this channel #46 of 79 here — alongside 78 others — read 5 September 2026
Медач | Medical Channel
@medach · 28,118
Telegram ranks this channel #50 of 97 here — alongside 96 others — read 10 September 2026

This channel appears in 4 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 17 September 2026 — this entry's latest reading, not the date you are reading this.

“Инновации в фармацевтике” (@chemrarpharma), 13,139 subscribers as measured 17 September 2026. Telegram Register, tgregister.com/channel/chemrarpharma.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.